TSS
RXRX icon

Two Sigma Securities’s Recursion Pharmaceuticals RXRX Stock Holding History

Two Sigma Securities’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-48,970
Closed -$200K – 2130
2025
Q4 		$200K Buy
48,970
+10,007
+26% +$49.6K 0.03% 872
2025
Q3 		$190K Sell
38,963
-3,494
-8% -$18.3K 0.03% 825
2025
Q2 		$215K Buy
42,457
+15,493
+57% +$76.1K 0.03% 880
2025
Q1 		$143K Buy
+26,964
New +$197K 0.02% 895

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Securities's RXRX Position: Q1 2026 in Review

Two Sigma Securities sold out of Recursion Pharmaceuticals (RXRX) in Q1 2026, closing a stake of 48,970 shares — an estimated $200K sold.

Two Sigma Securities first reported a position in RXRX in Q1 2025 and held it in 4 quarters. The position peaked at $215K in Q2 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Two Sigma Securities reported no remaining Recursion Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 48,970 Recursion Pharmaceuticals shares in Q1 2026, an estimated $200K.
  • Two Sigma Securities first reported a position in Recursion Pharmaceuticals in Q1 2025 and held it in 4 quarters.
  • Two Sigma Securities's Recursion Pharmaceuticals position peaked at $215K in Q2 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.